Prudential Financial Inc Xencor Inc Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Xencor Inc stock. As of the latest transaction made, Prudential Financial Inc holds 63,905 shares of XNCR stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,905

Previous 65,905 3.03%

Holding current value

$1.54 Million

Previous $1.25 Million 3.05%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$15.7 - $21.65 $31,400 - $43,300	-2,000 Reduced 3.03%	63,905 $1.29 Million
Q2 2024 Aug 13, 2024	SELL	$18.21 - $24.5 $50,805 - $68,355	-2,790 Reduced 4.06%	65,905 $1.25 Million
Q1 2024 May 14, 2024	SELL	$18.65 - $26.52 $23,499 - $33,415	-1,260 Reduced 1.8%	68,695 $1.52 Million
Q4 2023 Feb 13, 2024	SELL	$16.53 - $21.42 $10,546 - $13,665	-638 Reduced 0.9%	69,955 $1.49 Million
Q3 2023 Nov 13, 2023	SELL	$20.08 - $25.39 $71,986 - $91,023	-3,585 Reduced 4.83%	70,593 $1.42 Million
Q2 2023 Aug 11, 2023	BUY	$24.77 - $29.9 $397,682 - $480,044	16,055 Added 27.62%	74,178 $1.85 Million
Q1 2023 May 12, 2023	SELL	$25.95 - $36.95 $50,472 - $71,867	-1,945 Reduced 3.24%	58,123 $1.62 Million
Q4 2022 Feb 14, 2023	SELL	$24.79 - $30.86 $7,313 - $9,103	-295 Reduced 0.49%	60,068 $0
Q3 2022 Nov 04, 2022	SELL	$24.62 - $32.44 $9,355 - $12,327	-380 Reduced 0.63%	60,363 $1.57 Million
Q2 2022 Aug 15, 2022	SELL	$19.74 - $29.01 $1.43 Million - $2.1 Million	-72,250 Reduced 54.33%	60,743 $1.66 Million
Q1 2022 May 13, 2022	BUY	$26.68 - $41.63 $1.9 Million - $2.96 Million	71,080 Added 114.81%	132,993 $3.55 Million
Q4 2021 Feb 14, 2022	SELL	$33.67 - $43.44 $40,909 - $52,779	-1,215 Reduced 1.92%	61,913 $2.48 Million
Q3 2021 Nov 15, 2021	SELL	$30.65 - $35.68 $27,339 - $31,826	-892 Reduced 1.39%	63,128 $2.06 Million
Q2 2021 Aug 16, 2021	SELL	$34.33 - $44.68 $106,869 - $139,088	-3,113 Reduced 4.64%	64,020 $2.21 Million
Q1 2021 May 12, 2021	SELL	$40.81 - $53.88 $1.11 Million - $1.46 Million	-27,188 Reduced 28.82%	67,133 $2.89 Million
Q4 2020 Feb 16, 2021	SELL	$36.63 - $47.63 $5.36 Million - $6.97 Million	-146,250 Reduced 60.79%	94,321 $4.12 Million
Q3 2020 Nov 16, 2020	BUY	$30.09 - $43.02 $1.35 Million - $1.93 Million	44,956 Added 22.98%	240,571 $9.33 Million
Q2 2020 Aug 12, 2020	BUY	$27.76 - $33.42 $3.25 Million - $3.92 Million	117,169 Added 149.36%	195,615 $6.34 Million
Q1 2020 May 12, 2020	SELL	$20.69 - $37.79 $40,759 - $74,446	-1,970 Reduced 2.45%	78,446 $2.34 Million
Q4 2019 Feb 11, 2020	BUY	$32.75 - $41.43 $84,855 - $107,345	2,591 Added 3.33%	80,416 $2.77 Million
Q3 2019 Nov 13, 2019	BUY	$33.73 - $46.27 $2.45 Million - $3.37 Million	72,730 Added 1427.48%	77,825 $2.63 Million
Q2 2019 Aug 08, 2019	SELL	$29.6 - $40.93 $1.1 Million - $1.52 Million	-37,131 Reduced 87.93%	5,095 $0
Q1 2019 May 15, 2019	SELL	$27.85 - $38.09 $31,275 - $42,775	-1,123 Reduced 2.59%	42,226 $0
Q4 2018 Feb 07, 2019	SELL	$32.39 - $42.05 $1.63 Million - $2.12 Million	-50,387 Reduced 53.75%	43,349 $1.57 Million
Q3 2018 Nov 07, 2018	SELL	$35.69 - $47.65 $3.98 Million - $5.32 Million	-111,630 Reduced 54.36%	93,736 $0
Q2 2018 Aug 13, 2018	BUY	$28.41 - $42.41 $3.57 Million - $5.32 Million	125,500 Added 157.14%	205,366 $0
Q1 2018 May 04, 2018	BUY	$21.18 - $33.78 $889,348 - $1.42 Million	41,990 Added 110.86%	79,866 $0
Q4 2017 Feb 13, 2018	BUY	$19.29 - $24.83 $53,549 - $68,928	2,776 Added 7.91%	37,876 $830,000
Q3 2017 Nov 02, 2017	BUY	$19.61 - $23.35 $688,311 - $819,585	35,100	35,100 $804,000

Others Institutions Holding XNCR

# of Institutions

215

Shares Held

71.5M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.44B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Xencor Inc Transaction History